The Virginian-Pilot 
                             THE VIRGINIAN-PILOT 
              Copyright (c) 1994, Landmark Communications, Inc.

DATE: Saturday, July 30, 1994                TAG: 9407300205
SECTION: FRONT                    PAGE: A2   EDITION: FINAL 
SOURCE: ASSOCIATED PRESS 
DATELINE: WASHINGTON                         LENGTH: Short :   21 lines

FDA CONSIDERS AZT FOR PREGNANT WOMEN WHO ARE HIV-POSITIVE

The AIDS drug AZT should be approved for use by HIV-infected pregnant women to prevent spread of the disease to their babies, a Food and Drug Administration advisory panel recommended.

Burroughs Wellcome Co., which makes AZT under the trade name Retrovir, said studies showed pregnant women using the drug after the 14th week of gestation can reduce HIV transmission to their unborn infants by two-thirds.

KEYWORDS: AIDS by CNB